View Cart  

Sorin Group Announces U.S. Launch of New Heart Device for Simultaneous Implantation of an Aortic Tissue Valve and Ascending Aorta

A A
Sorin announced today the U.S. commercial launch of the Mitroflow Valsalva Conduit, the only Valsalva conduit graft approved by the FDA for use in combination with an aortic tissue valve.
The Herald